Amgen Ltd: UK Public Sector Contracts Won & Awards

Large organisationCompanies House: Private Limited CompanyCambridgeNationwide (UK)Main market: Pharmaceutical products

Official UK PPONPDJG-8184-TCQQCompanies House02354269 ↗ · Active

Where they win
i

56 awards (53 for a named lot, 95%, 3 for a whole procedure with no lot named) · top CPV classes, shares of all 56 awards. An award may cover more than one class.

3360 Pharmaceutical products56 awards · 100% · 53 awards naming a lot + 3 whole-procedure awards
Attributable award value
i
£14mOn 5 of 56 award records; the five largest make 100%. Largest rows below.
Typical attributable award
i
£1.9m middle valuerobust · n=5

Where their buyers are
i

ITL1 region of the buyer office · known for 49 of 49 awarded procedures · each procedure counts once

Greater London26 procedures · 53%
Wales (Cymru)9 procedures · 18%
Scotland8 procedures · 16%
North West England4 procedures · 8%
Northern Ireland2 procedures · 4%

Bidding record
i

Procurement Act 2023 award notices name every bidder · 4 notices name this supplier, covering 6 lots since 6 Oct 2025 · observed bids, not an estimate

Contract lots contested
i
0 won · 0 lostFewer than three decided lots: no rate is claimed.
Framework / DPS places
i
4 of 6Lots on 4 notices: a place is won per lot.
Authorities bid for
i
1

Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.

Who they sell to
i

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i
  • NHS & health89%(50 awards)
    50 of 56 awards are NHS & health (89%).
  • Type not classified11%(6 awards)
    6 of 56 awards are Type not classified (11%).
AuthorityProceduresShareAward recordsLast activity
NHS Englandframework/DPS on 232653.1%356 Jul 2026
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")framework/DPS on 8816.3%1218 Dec 2025
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)framework/DPS on 1816.3%84 Jun 2026
The NHS Commissioning Board (operating under the name of NHS England)framework/DPS on 448.2%67 Feb 2022
Business Services Organisation Procurement and Logistics Serviceframework/DPS on 224.1%512 Jun 2025
eTenderwales12%123 Apr 2025

Share = of the 49 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

53 of 67 awards carry an end date, 10 estimated from the duration · not a retender forecast

ContractEndsPublished value
Lot 2 - CM/TNS/25/5725/0231 Dec 2026£15,059,000 ceiling
Cancer Medicines (Group 2)31 Jan 2027£18,207,081 ceiling
NP49425 Generic and Biosimilar Transition Medicines28 Feb 2027£64,103,740 ceiling
Medicinal Products - Direct to Trust2 Jun 2027 estimated£210,000,000 ceiling
Medicinal Products - with Pharma Funded Homecare Services2 Jun 2027 estimated£174,000,000 ceiling
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 202531 Aug 2027£986,282,758
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National31 Aug 2027£261,895,933
Lot 2 - CM/PHR/25/5731/02 - Ustekinumab NOFE & MAE31 Aug 2027£18,903,212 ceiling
Transitional Drugs 629 Feb 2028£1,637,726
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 202430 Apr 2028£1 ceiling

Recent awards

Latest 30 of 56 award records naming this supplier

Contracts Finder adds 11 more procedures won by this supplier, mostly below the Find a Tender threshold or from before 2025. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.

Award / procedureAuthorityAwardedPublished value
Biologic and Biosimilar MedicineseTenderwalesNot published£8,750,400 †
from the contract notice
Transitional Drugs 3NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)Not published£3,518,112 †
from the contract notice
UstekinumbNHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)Not published£280,540 †
from the contract notice
NHS Framework for the supply of Ustekinumab - London & South of England.NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
NHS Framework for the supply of Ustekinumab - North of England and Midlands & EastNHS EnglandNot published£1 †
framework ceiling · not attributable revenue
UstekinumabThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£11,680,128 †
framework ceiling · 1 of 6 appointed suppliers
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche ANHS EnglandNot published£1 †
framework ceiling · not attributable revenue
NP47923b TocilizumabThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£44,618,492 †
framework ceiling · 1 of 6 appointed suppliers
NP47923b TocilizumabThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£10,508,400 †
framework ceiling · 1 of 3 appointed suppliers
About this data
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
  • Contract end dates. Published on 43 of 67 awards, estimated from the published duration on 10 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
  • Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.